Clinical Trial Update: Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial comparing cabergoline to calcium gluconate infusion for prevention of ovarian hyperstimulation syndrome (OHSS) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CABERGOLINE (CABERGOLINE)
• CALCIUM GLUCONATE (Calcium gluconate)

Snippet

Sponsor: Aljazeera Hospital | Conditions: OHSS | Phase 2 | Status: COMPLETED